| ERAS® Cardiac Society Turnkey Order Set for Surgical Site Infection Prevention: Proceedings from the AATS ERAS Conclave 2023. C Crisafi, MC Grant, A Rea, V Morton-Bailey, AJ Gregory, RC Arora, ... The Journal of Thoracic and Cardiovascular Surgery, S0022-5223 (24) 00281, 2024 | | 2024 |
| Disparities in access to and timing of interventional therapies for pulmonary embolism across the United States B Rush, J Ziegler, S Dyck, S Dhaliwal, O Mooney, S Lother, LA Celi, ... Journal of Thrombosis and Haemostasis, 2024 | | 2024 |
| Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19 LC Godoy, MD Neal, EC Goligher, M Cushman, BL Houston, CA Bradbury, ... JACC: Advances 3 (3), 100780, 2024 | 2 | 2024 |
| AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023–2024 JM Grant, J Lam, SV Goyal, S Lother, SS Kassim, SB Lee, J Chan, ... Journal of the Association of Medical Microbiology and Infectious Disease …, 2024 | | 2024 |
| Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ... JAMA 330 (18), 1745-1759, 2023 | 10 | 2023 |
| Continuation of therapeutic dose heparin for critically ill patients with COVID-19 CA Bradbury, PR Lawler, BJ McVerry, R Zarychanski Intensive care medicine 49 (7), 873-875, 2023 | 4 | 2023 |
| Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support–free days in patients hospitalized with COVID-19: a randomized … S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ... JAMA 329 (14), 1183-1196, 2023 | 32 | 2023 |
| Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19 EC Goligher, PR Lawler, TP Jensen, V Talisa, LR Berry, E Lorenzi, ... JAMA 329 (13), 1066-1077, 2023 | 41 | 2023 |
| Outcomes with severe pulmonary coccidioidomycosis and respiratory failure in the United States B Rush, J Zeigler, MP Cheng, C Hrymak, S Lother Journal of the Association of Medical Microbiology and Infectious Disease …, 2023 | 1 | 2023 |
| Long-Term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... JAMA 329 (1), 39-51, 2023 | 88 | 2023 |
| AMMI Canada Practice Point: Treatments for adults with COVID-19 in 2021–2022 JM Grant, J Chan, SA Lother, L Barrett, PE Bonnar, AR Findlater, ... Official Journal of the Association of Medical Microbiology and Infectious …, 2022 | 2 | 2022 |
| Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison … ZN Sohani, G Butler-Laporte, A Aw, S Belga, A Benedetti, A Carignan, ... BMJ open 12 (7), e053039, 2022 | 5 | 2022 |
| Surgical Triage and Timing for Patients with COVID: A Guidance Statement from the Society of Thoracic Surgeons MC Grant, SA Lother, DT Engelman, A Hassan, P Atluri, R Moosdorf, ... The Annals of Thoracic Surgery, 2022 | 5 | 2022 |
| Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... JAMA 327 (13), 1247-1259, 2022 | 88 | 2022 |
| Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19 P Bégin, J Callum, R Cook, E Jamula, Y Liu, A Finzi, DM Arnold Nature Medicine 28 (1), 53-58, 2022 | 1 | 2022 |
| Persistence of live virus in critically ill patients infected with SARS-CoV-2: A prospective observational study SJ Funk DJ, Bullard J, Lother SA, Vazquez-Grande G, Garnett L, Doan K, Dust ... Critical Care 26 (10), 1-7, 2022 | 13* | 2022 |
| Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... JAMA 326 (17), 1690-1702, 2021 | 193 | 2021 |
| Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial P Bégin, J Callum, E Jamula, R Cook, NM Heddle, A Tinmouth, MP Zeller, ... Nature medicine 27 (11), 2012-2024, 2021 | 247 | 2021 |
| Perioperative Coronavirus Vaccination—Timing and Implications: A Guidance Document HM Merritt-Genore, R Moosdorf, E Gillaspie, S Lother, D Engelman, ... The Annals of Thoracic Surgery 112 (5), 1707-1715, 2021 | 17 | 2021 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1043 | 2021 |
